Cetuximab: First report of posterior reversible leukoencephalopathy syndrome, leading to nonconvulsive status epilepticus: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1376, 2011-01, pp. : 10-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib: First report of reversible posterior leukoencephalopathy syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1128, 2006-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Etanercept: First report of reversible posterior leukoencephalopathy syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Midodrine: First report of reversible posterior leukoencephalopathy syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1156, 2007-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Pseudoephedrine: First report of reversible posterior leukoencephalopathy syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. : 38-39

Adis International

Access to resources Recommend Favorite

Carbamazepine: Hypertension leading to reversible posterior leukoencephalopathy syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1264, 2009-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite